Jameson Legal

 

Resource

 

 

 

 

 

 

 

 

 

 

 

Ashurst advises CHA Healthcare and Singapore Medical Group on their 65% acquisition of City Fertility Clinics

06 Feb 2018

Ashurst has advised CHA Healthcare Singapore Pte Ltd (CHA Healthcare) and Singapore Medical Group Limited (SMG) (together, the Consortium) on their acquisition of approximately 65% of City Fertility Clinics, which are operated by CFC Global Pty Ltd (CFC Global), the fourth largest fertility services provider in Australia.

CFC Global operates seven clinics to provide laboratory, nursing and IVF services. The business also includes genetic testing support, and sperm and egg donor services.

The remaining interest in CFC Global will be held by its management. This transaction is the Consortium's first entry into the Australian market.

CHA Healthcare is part of the CHA Medical Group, one of South Korea's largest medical groups offering healthcare services through hospitals and clinics in the United States and Japan. SMG is a Singapore listed specialist healthcare provider in Singapore with a key focus on women's health.

The Ashurst team was led by partner Nigel Deed (Corporate), and included senior consultant Wayne Cahill, senior associate Genovieve Lajeunesse, lawyers Rachel Tate and Diana Oh, with graduate Sarah Yang (Corporate); partner Jennie Mansfield with lawyer Ffion Whaley (Employment); senior associate Gaby Stach and lawyer Jake Saccardo (Property); partner Tim Brookes with graduate Emily McCracken (Privacy); partner Anita Cade and associate Eoin Martyn (IP); lawyer Marie Vlassis (Insurance); with partner Kenneth Tang and associate Rashi Lordan (Global Loans).

Matter Type
M&A: Acquiror's Counsel
Industry
Healthcare, Life Sciences & Chemicals
News Category
M&A